Ayesha Ahmad
Clinical Professor of Pediatrics and Medical Director
Pediatric Specialty ACU
[email protected]

Available to mentor
Ayesha Ahmad
Clinical Professor
  • Recent Publications
    • Recent Publications See All Publications
    • Journal Article
      P.40 Nutritional changes after an AAV8-mediated liver-directed gene therapy in adults with glycogen storage disease type Ia (GSD Ia)
      Saavedra H, Mount M, Lipinski S, Camba-Garea M-J, de Boer F, Boney A, Rodriguez-Buritica D, Riba-Wolman R, Ahmad A, Pico MC, Derks T, Mitchell J, Mitragotri D, Grimm A. Molecular Genetics and Metabolism, 2024 Apr; 141: 108406 DOI:10.1016/j.ymgme.2024.108406
    • Journal Article
      Trial interviews to explore glycogen storage disease type Ia patient experiences of gene therapy
      Turner-Bowker D, Malkus B, Egan S, Weinstein D, Derks TGJ, Rodriguez-Buritica DF, Ahmad A, Couce ML, Mitchell JJ, Riba-Wolman R, Butler J. Molecular Genetics and Metabolism, 2024 Apr; 141 (4): 108269 DOI:10.1016/j.ymgme.2024.108269
    • Journal Article
      P693: Novel combined molecular diagnosis of rare digynic triploidy in preterm neonates
      Yang C, Ahmad A, Beil A, Ducharme N, Kubisak A, Rabah R. Genetics in Medicine Open, 2024 2: 101597 DOI:10.1016/j.gimo.2024.101597
    • Journal Article
      Results of the ACTION-Galactosemia Kids Study to Evaluate the Effects of Govorestat in Pediatric Patients with Classic Galactosemia.
      Bailey E, Phan H, Ahmad A, Thomas J, Ames EG, Pritchard AB, Quinonez SC, Wang S, Dayley C, Salt A, Pick C, Durrant A, Johnson S, Nicodemus-Johnson J, Dickson SP, Perfetti R, Hendrix SB, Shendelman S. J Clin Pharmacol, 2024 Nov 21; DOI:10.1002/jcph.6170
      PMID: 39569553
    • Proceeding / Abstract / Poster
      Seriously different versions of mucopolysaccharidosis type VII
      Fisher R, Ahmad A, Ames E. Molecular Genetics and Metabolism, 2023 Feb; 138 (2): 107100 DOI:10.1016/j.ymgme.2022.107100
    • Proceeding / Abstract / Poster
      Efficacy and Safety at Week 52 and up to Four Years in Adults with Glycogen Storage Disease Type IA (GSDIa): Results from a Phase 1/2 Clinical Trial and Long-Term Follow-Up Study of DTX401, an AAV8-Mediated, Liver-Directed Gene Therapy
      Riba-Wolman R, Rodriguez-Buritica DF, Ahmad A, Couce Pico M-L, Derks TG, Mitchell J, Weinstein DA, Mitragotri D, Grimm AA, Crombez E. MOLECULAR THERAPY, 2023 31 (4): 2 - 3.
    • Proceeding / Abstract / Poster
      mRNA-3927 Therapy for Propionic Acidemia: Interim Data from a Phase 1/2 Study
      Grunewald S, Santra S, Koeberl D, Schulze A, Sondheimer N, Ahmad A, Lipshutz GS, Geberhiwot T, Liang M, Li L, Glaser R, Carrillo N. MOLECULAR THERAPY, 2023 31 (4): 102 - 103.
    • Journal Article
      Usability of NewSTEPs Data for Assessing the Characteristics of Infants with Newborn Screening Disorders.
      Omari A, Reeves SL, Prosser LA, Creary MS, Ahmad A, Chua K-P. Int J Neonatal Screen, 2022 Jul 19; 8 (3): DOI:10.3390/ijns8030042
      PMID: 35892472